SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS. Mueller Christian et al. The New England journal of medicine 2020 Jul (2) 151-158

Hot Topics of the Day|PHGKB


Last Posted: Jul 09, 2020

---

• SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
  Mueller Christian et al. The New England journal of medicine 2020 Jul (2) 151-158
• Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
  Miller Timothy et al. The New England journal of medicine 2020 Jul (2) 109-119
• The Beginning of Genomic Therapies for ALS.
  Hardiman Orla et al. The New England journal of medicine 2020 Jul (2) 180-181
• Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.
  Scarlino Stefania et al. International journal of molecular sciences 2020 May 21(9)
• Prevalence of C9orf72 hexanucleotide repeat expansion in Greek patients with sporadic ALS.
  Sokratous Maria et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2020 Apr 1-3
• Molecular analysis and clinical diversity of distal hereditary motor neuropathy.
  Liu Xiaoxuan et al. European journal of neurology 2020 Apr
• Prediction of caregiver burden in amyotrophic lateral sclerosis: a machine learning approach using random forests applied to a cohort study.
  Antoniadi Anna Markella et al. BMJ open 2020 Feb 10(2) e033109
• Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update.
  Garcia-Santibanez Rocio et al. Current neurology and neuroscience reports 2018 18(12) 93
• CMS-01 Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challenges.
  Crook Ashley et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2019 Nov 20(sup1) 327-347
• NIH's All of Us Partners with HudsonAlpha on Long-Read Sequencing Project
  Clinical Omics, October 18, 2019

more